Type III interferon is a critical regulator of innate antifungal immunity.
Type III interferon is a critical regulator of innate antifungal immunity.
复制标题
DOI:
10.1126/sciimmunol.aan5357
复制
发表时间:
2017-10-06
影响因子:
24.8
通讯作者:
Rivera A
中科院分区:
文献类型:
--
作者:
Espinosa V;Dutta O;McElrath C;Du P;Chang YJ;Cicciarelli B;Pitler A;Whitehead I;Obar JJ;Durbin JE;Kotenko SV;Rivera A
Type III interferons (IFN-λs) are the most recently found members of the IFN cytokine family and engage IFNLR1 and IL10R2 receptor subunits to activate innate responses against viruses. We have identified IFN-λs as critical instructors of antifungal neutrophil responses. Using Aspergillus fumigatus (Af) as a model to study antifungal immune responses, we found that depletion of CCR2+ monocytes compromised the ability of neutrophils to control invasive fungal growth. Using an unbiased approach, we identified type I and III IFNs as critical regulators of the interplay between monocytes and neutrophils responding to Af. We found that CCR2+ monocytes are an important early source of type I IFNs that prime optimal expression of IFN-λ. Type III IFNs act directly on neutrophils to activate their antifungal response, and mice with neutrophil-specific deletion of IFNLR1 succumb to invasive aspergillosis. Dysfunctional neutrophil responses in CCR2-depleted mice were rescued by adoptive transfer of pulmonary CCR2+ monocytes or by exogenous administration of IFN-α and IFN-λ. Thus, CCR2+ monocytes promote optimal activation of antifungal neutrophils by initiating a coordinated IFN response. We have identified type III IFNs as critical regulators of neutrophil activation and type I IFNs as early stimulators of IFN-λ expression.
登录
查看更多内容
影响因子:
30.3
作者:
Hohl TM;Rivera A;Lipuma L;Gallegos A;Shi C;Mack M;Pamer EG
通讯作者:
Pamer EG
DOI:
10.1084/jem.158.3.670
发表时间:
1983-09-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Nathan CF;Murray HW;Wiebe ME;Rubin BY
通讯作者:
Rubin BY
影响因子:
6.7
作者:
Crotta S;Davidson S;Mahlakoiv T;Desmet CJ;Buckwalter MR;Albert ML;Staeheli P;Wack A
通讯作者:
Wack A
DOI:
10.1084/jem.20140995
发表时间:
2015-06-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Blazek K;Eames HL;Weiss M;Byrne AJ;Perocheau D;Pease JE;Doyle S;McCann F;Williams RO;Udalova IA
通讯作者:
Udalova IA
影响因子:
30.5
作者:
Broggi A;Tan Y;Granucci F;Zanoni I
通讯作者:
Zanoni I